Jack Truong
Operator
Well, good morning, everyone. Welcome to our Q4 fiscal year '19 earnings call. Thank you for joining us today. I'm Jack Truong, CEO of James Hardie group, and with me here today is Matt Marsh, group CFO. And both of us will share with you the results for fiscal year '19, and then we're going to share with you where we're going with our strategy and the status of our strategy. So firstly, on the agenda, we'll have -- so I would briefly go over the operating review for the company in the fiscal year '19, and Matt will come up and share with you in more detail on the financial results of the quarter and also the year. And I'll get back up and really share with you the progress of the 3-year strategy that we shared with you 3 months ago, where we are relative to the execution along that 3-year horizon. And then we'll end with the Q&A. Now let's move on to our group results of fiscal year '19. I'm very pleased to announce that this is the first year that we, as a group at James Hardie, crossed the $2.5 billion mark. And what is even more significant is that we now operate in 3 major regions around the world: North America, Asia Pacific and Europe. And the discussion today will be a lot more in depth about those 3 -- the results in the 3 regions for the whole fiscal year '19 because this is the first year that Fermacell results are in, in our results for that whole fiscal year. So if you look at our year in review, North America delivered improved PDG, although it's below expectations. So if you look at our PDG for fiscal year '19, we are north of…